GWP.L Regulatory News (GWP)

19 Mar 2008 15:29

GW Pharmaceuticals PLC19 March 2008 For immediate release 19 March 2008 GW Pharmaceuticals plc ("the Company") Notification of Interests of Directors Following shareholder approval at yesterday's AGM of the GW Pharmaceuticals plcLong-Term Incentive Plan, the Company has granted the following awards toDirectors over the Company's ordinary shares ("Shares"). On 19 March 2008, the Company granted the following awards in the form ofnominal-cost options ("Awards") under the GW Pharmaceuticals plc Long-TermIncentive Plan: Name Number of Shares under Award Total number of Shares over which options / awards heldDr Geoffrey Guy 170,000 1,789,914Justin Gover 153,000 2,079,469David Kirk 137,000 2,273,136Dr Stephen Wright 140,000 1,177,180 The exercise price of the Awards is 0.1p per Share, the par value of the Shares. The Awards will ordinarily vest on 19 March 2011, subject to regulatory approvalof the Company's lead product, Sativex(R), being achieved in any one of the UK,France, Germany, Italy or Spain. Once vested, an Award may be exercised at anytime prior to the tenth anniversary of the date of grant. For further information please contact Adam George, Company Secretary &Financial Controller, GW Pharmaceuticals plc on 01980 557 000. This information is provided by RNS The company news service from the London Stock Exchange